APEN Apollo Endosurgery


Data from SEC filings
Employee count

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM
On June 17, 2021, the Company held its 2021 Annual Meeting. As of April 26, 2021, the record date for the 2021 Annual Meeting, there were a total of 27,035,842 shares of common stock outstanding and entitled to vote. At the 2021 Annual Meeting, 22,563,533 shares of the Company's common stock, or approximately 83.5% of the voting power of shares outstanding as of the record date, were represented in person or by proxy, constituting a quorum. The following proposals were adopted at the 2021 Annual Meeting by the margin indicated. Proxies for the 2021 Annual Meeting were solicited pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amended, and there was no solicitation in opposition of management’s solicitation.

(a) Proposal 1. To elect the three Class I nominees to the Board of Directors of the Company to hold office until the 2024 Annual Meeting of Stockholders and until their successors are duly elected and qualified, subject to their earlier resignation or removal.
NameVotes ForVotes WithheldBroker Non-Votes
David C. Pacitti10,032,908 796,992 9,748,789
William D. McClellan, Jr.12,537,374 277,342 9,748,789
Julie Shimer, Ph.D.12,475,046 319,168 9,768,669

(b) Proposal 2. The selection of Moss Adams LLP to act as our independent registered public accounting firm for the year ending December 31, 2021 was ratified based upon the following votes:
Votes for22,560,415
Votes Against274